Evidence map›Paper›PMID 25989500›Full record

ArticleTransplantation2015

Stimulation of Dopamine D3 Receptor Attenuates Renal Ischemia-Reperfusion Injury via Increased Linkage With Gα12.

Zhen Wang, Weiwei Guan, Yu Han, Hongmei Ren, Xiaofeng Tang, Hui Zhang, Yukai Liu, Jinjuan Fu, Duofen He, Laureano D Asico and 4 more

Abstract read
In one paragraph

Article in Transplantation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.0field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. GRespiratory research · 2024
    Review
  3. Article
  4. Review
  5. GαFrontiers in cell and developmental biology · 2022
    Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Newly Developed Dopamine DThe Journal of pharmacology and experimental therapeutics · 2019
    Article
  11. Article
  12. ICU Management of the Potential Organ Donor: State of the Art.Current neurology and neuroscience reports · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Zhen Wang1 Department of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing, P.R. China. 2 Department of Anesthesiology, Daping Hospital, The Third Military Medical University, Chongqing, P.R. China. 3 Chongqing Institute of Cardiology, Chongqing, P.R. China. 4 Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD. 5 Department of Physiology, University of Maryland School of Medicine, Baltimore, MD.
Weiwei Guan
Yu Han
Hongmei Ren
Xiaofeng Tang
Hui Zhang
Yukai Liu
Jinjuan Fu
Duofen He
Laureano D Asico
Pedro A Jose
Lin Zhou
Liyong Chen
Chunyu Zeng
Army Medical University · CNDaping Hospital · CNUniversity of Maryland, Baltimore · US

Funding

Spatiotemporal transregulation of D1-like angiotensin receptors in genetically...P01HL074940 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI GILDEA, JOHN JOSEPH · 2004 to 2020
$31.8M
NHLBI NIH HHS HL0749400NHLBI NIH HHS P01 HL074940
6 · The paper itself

Abstract

backgroundRenal ischemia-reperfusion (I/R) injury causes renal tubular necrosis, apoptosis, and inflammation leading to acute renal dysfunction. Recent studies have revealed that deletion of Gα12 mitigates the renal damage due to I/R injury. Our previous study showed that activation of dopamine D3 receptor (D3R) increased its linkage with Gα12, and hampered Gα12-mediated stimulation of renal sodium transport. In the present study, we used an in-vivo rat model and an in vitro study of the renal epithelial cell line (NRK52E) to investigate whether or not an increased linkage between D3R and Gα12 contributes to the protective effect of D3R on renal I/R injury.

methodsFor in vivo studies, I/R injury was induced in a rat renal unilateral clamping model. For in vitro studies, hypoxia/reoxygenation and cold storage/rewarming injuries were performed in NRK52E cells. PD128907, a D3R agonist, or vehicle, was administered 15 minutes before clamping (or hypoxia) in both the in vivo or in vitro studies.

resultsIn the rat renal unilateral clamping model, pretreatment with PD128907 (0.2 mg/kg, intravenous) protected against renal I/R injury and increased survival rate during a long-term follow-up after 7 days. A decrease in the generation of reactive oxygen species, apoptosis, and inflammation may be involved in the D3R-mediated protection because pretreatment with PD128907 increased renal glutathione and superoxide dismutase levels and decreased malondialdehyde levels in the I/R group. The increase in cytokines (TNF-α, IL-1β, and IL-10) and myeloperoxidase in I/R injured kidney was also prevented with a simultaneous decrease in the apoptosis of the epithelial cells and expression of apoptosis biomarkers in kidney harvested 1 day after I/R injury. The increase in the coimmunoprecipitation between D3R and Gα12 with D3R stimulation paralleled the observed renal protection from I/R injury. Moreover, in vitro studies showed that transient overexpression of Gα12 in the NRK52E cells attenuated the protective effect of PD128907 on hypoxia/reoxygenation injury. The protective effect of PD128907 might be of significance to renal transplantation because cold storage/rewarming induced injury increased lactate dehydrogenase release and decreased cell viability in NRK52E cells. Conversely, in the presence of PD128907, the increased lactate dehydrogenase release and decreased cell viability were reversed.

conclusionsThese results suggest that activation of D3R, by decreasing Gα12-induced renal damage, may exert a protective effect from I/R injury.

Indexed as

Acute Kidney InjuryAnimalsApoptosisBenzopyransCell LineCell SurvivalCytoprotectionDisease Models, AnimalDopamine AgonistsEpithelial CellsGlutathioneGTP-Binding Protein alpha Subunits, G12-G13Inflammation MediatorsKidneyMaleMalondialdehyde3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-olBenzopyransDopamine AgonistsDrd3 protein, ratGlutathioneGTP-Binding Protein alpha Subunits, G12-G13Inflammation MediatorsMalondialdehydeOxazinesReceptors, Dopamine D3Superoxide Dismutase

Identifiers

PMID25989500
PMCPMC4618723
OpenAlexW318192732

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.